Friedreich's ataxia, frataxin, PIP5K1B: Echo of a distant fracas

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Bayot, Aurélien ^a,b   Rustin, Pierre ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDATE GENES; FRATAXIN; FRIEDREICH'S ATAXIAS;

GENE EXPRESSION; NEURODEGENERATIVE DISEASES;

EXPANSION;

BIOLOGICAL MARKER; FRATAXIN; MESSENGER RNA; PIP5K1B PROTEIN; UNCLASSIFIED DRUG; 1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; IRON BINDING PROTEIN; IRON SULFUR PROTEIN; PHOSPHOTRANSFERASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE;

ALLELE; ARTICLE; DNA STRUCTURE; FIBROBLAST; FRIEDREICH ATAXIA; GENE EXPRESSION; HUMAN; HYPERSENSITIVITY; INTRON; NONHUMAN; OXIDATIVE STRESS; TRANSCRIPTION INITIATION; ANIMAL; DEFICIENCY; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; TRINUCLEOTIDE REPEAT; REVIEW;

ANIMALS; FRIEDREICH ATAXIA; HUMANS; IRON-BINDING PROTEINS; IRON-SULFUR PROTEINS; OXIDATIVE STRESS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84886650601     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/725635     Document Type: Article

References (55)

1. Harding A. E., Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981 104 3 589 620 2-s2.0-0019782799 (Pubitemid 12202197)
2. Koeppen A. H., Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. Journal of the Neurological Sciences 2011 303 1-2 1 12 2-s2.0-79952814526 10.1016/j.jns.2011.01.010
3. Dürr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C., Mandel J.-L., Brice A., Koenig M., Clinical and genetic abnormalities in patients with Friedreich's ataxia. The New England Journal of Medicine 1996 335 16 1169 1175 2-s2.0-0029821176 10.1056/NEJM199610173351601 (Pubitemid 26339770)
4. Bidichandani S. I., Delatycki M. B., Pagon R. A., Adam M. P., Bird T. D., Dolan C. R., Fong C. T., Stephens K., Friedreich ataxia. GeneReviews 1998 1993-2012 Seattle, Wash, USA University of Washington
5. de Castro M., García-Planells J., Monrós E., Cañizares J., Vázquez-Manrique R., Vílchez J. J., Urtasun M., Lucas M., Navarro G., Izquierdo G., Moltó M. D., Palau F., Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients. Human Genetics 2000 106 1 86 92 2-s2.0-0343340403 (Pubitemid 30156399)
6. Campuzano V., Montermini L., Moltò M. D., Pianese L., Cossée M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Cañizares J., Koutnikova H., Bidichandani S. I., Gellera C., Brice A., Trouillas P., de Michele G., Filla A., de Frutos R., Palau F., Patel P. I., di Donato S., Mandel J.-L., Cocozza S., Koenig M., Pandolfo M., Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996 271 5254 1423 1427 2-s2.0-13344270899 (Pubitemid 26089479)
7. Cossée M., Campuzano V., Koutnikova H., Fischbeck K., Mandel J. L., Koenig M., Bidichandani S. I., Patel P. I., Moltè M. D., Cañizares J., de Frutos R., Pianese L., Cavalcanti F., Monticelli A., Cocozza S., Montermini L., Pandolfo M., Frataxin fracas. Nature Genetics 1997 15 4 337 338 2-s2.0-0031110672
8. Carvajal J. J., Pook M. A., dos Santos M., Doudney K., Hillermann R., Minogue S., Williamson R., Hsuan J. J., Chamberlain S., The Friedreich's ataxia gene encodes a novel phosphatidylinositol-4-phosphate 5-kinase. Nature Genetics 1996 14 2 157 162 2-s2.0-0029840038 10.1038/ng1096-157 (Pubitemid 26338795)
9. Rötig A., de Lonlay P., Chretien D., Foury F., Koenig M., Sidi D., Munnich A., Rustin P., Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nature Genetics 1997 17 2 215 217 2-s2.0-0031253821
10. Mühlenhoff U., Richhardt N., Ristow M., Kispal G., Lill R., The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Human Molecular Genetics 2002 11 17 2025 2036 2-s2.0-0037101845 (Pubitemid 34919277)
11. Stehling O., Elsässer H.-P., Brückel B., Mühlenhoff U., Lill R., Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Human Molecular Genetics 2004 13 23 3007 3015 2-s2.0-9744248303 10.1093/hmg/ddh324 (Pubitemid 39585233)
12. Stehling O., Lill R., The role of mitochondria in cellular iron-sulfur protein biogenesis: mechanisms, connected processes, and diseases. Cold Spring Harbor Perspectives in Biology 2013 5 8 10.1101/cshperspect.a011312
13. Bayot A., Santos R., Camadro J.-M., Rustin P., Friedreich's ataxia: the vicious circle hypothesis revisited. BMC Medicine 2011 9, article no. 112 2-s2.0-80053628321 10.1186/1741-7015-9-112
14. Martelli A., Wattenhofer-Donzé M., Schmucker S., Bouvet S., Reutenauer L., Puccio H., Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues. Human Molecular Genetics 2007 16 22 2651 2658 2-s2.0-35449008450 10.1093/hmg/ddm163 (Pubitemid 350018507)
15. Chantrel-Groussard K., Geromel V., Puccio H., Koenig M., Munnich A., Rötig A., Rustin P., Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Human Molecular Genetics 2001 10 19 2061 2067 2-s2.0-0034778392 (Pubitemid 32998818)
16. Paupe V., Dassa E. P., Goncalves S., Auchère F., Lönn M., Holmgren A., Rustin P., Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS ONE 2009 4 1, article e4253 2-s2.0-64249161639 10.1371/journal.pone.0004253
17. Pastore A., Tozzi G., Gaeta L. M., Bertini E., Serafini V., di Cesare S., Bonetto V., Casoni F., Carrozzo R., Federici G., Piemonte F., Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. Journal of Biological Chemistry 2003 278 43 42588 42595 2-s2.0-0142211205 10.1074/jbc.M301872200 (Pubitemid 37310532)
18. He F., Todd P. K., Epigenetics in nucleotide repeat expansion disorders. Seminars in Neurology 2011 31 5 470 483 2-s2.0-84856147847 10.1055/s-0031- 1299786
19. Bayot A., Reichman S., Lebon S., Csaba Z., Aubry L., Sterkers G., Husson I., Rak M., Rustin P., Cis-silencing of PIP5K1B evidenced in Friedreich's ataxia patient cells results in cytoskeleton anomalies. Human Molecular Genetics 2013 22 2894 2904 10.1093/hmg/ddt144
20. Nakamori M., Thornton C., Epigenetic changes and non-coding expanded repeats. Neurobiology of Disease 2010 39 1 21 27 2-s2.0-77952889125 10.1016/j.nbd.2010.02.004
21. Bidichandani S. I., Ashizawa T., Patel P. I., The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. American Journal of Human Genetics 1998 62 1 111 121 2-s2.0-0031941447 10.1086/301680 (Pubitemid 28093840)
22. Saveliev A., Everett C., Sharpe T., Webster Z., Festenstein R., DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature 2003 422 6934 909 913 10.1038/nature01596 (Pubitemid 36520045)
23. Sandi C., Al-Mahdawi S., Pook M. A., Epigenetics in Friedreich's ataxia: challenges and opportunities for therapy. Genetics Research International 2013 2013 12 852080 10.1155/2013/852080
24. Gottesfeld J. M., Small molecules affecting transcription in Friedreich ataxia. Pharmacology & Therapeutics 2007 116 2 236 248 2-s2.0-34748841015 10.1016/j.pharmthera.2007.06.014 (Pubitemid 47469990)
25. Herman D., Jenssen K., Burnett R., Soragni E., Perlman S. L., Gottesfeld J. M., Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nature Chemical Biology 2006 2 10 551 558 10.1038/nchembio815 (Pubitemid 44413238)
26. Rai M., Soragni E., Chou C. J., Barnes G., Jones S., Rusche J. R., Gottesfeld J. M., Pandolfo M., Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PloS ONE 2010 5 1, article e8825 2-s2.0-77952530173 10.1371/journal.pone.0008825
27. Rai M., Soragni E., Jenssen K., Burnett R., Herman D., Coppola G., Geschwind D. H., Gottesfeld J. M., Pandolfo M., HDAC inihibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS ONE 2008 3 4, article e1958 2-s2.0-44349114629 10.1371/journal.pone.0001958 (Pubitemid 351984393)
28. Sandi C., Pinto R. M., Al-Mahdawi S., Ezzatizadeh V., Barnes G., Jones S., Rusche J. R., Gottesfeld J. M., Pook M. A., Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiology of Disease 2011 42 3 496 505 2-s2.0-79954628287 10.1016/j.nbd.2011.02.016
29. Kim E., Napierala M., Dent S. Y. R., Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia. Nucleic Acids Research 2011 39 19 8366 8377 2-s2.0-80455149647 10.1093/nar/gkr542
30. Punga T., Bühler M., Long intronic GAA repeats causing Friedreich ataxia impede transcription elongation. EMBO Molecular Medicine 2010 2 4 120 129 2-s2.0-77953659252 10.1002/emmm.201000064
31. Kumari D., Biacsi R. E., Usdin K., Repeat expansion affects both transcription initiation and elongation in Friedreich ataxia cells. Journal of Biological Chemistry 2011 286 6 4209 4215 2-s2.0-79953006870 10.1074/jbc.M110.194035
32. de Biase I., Chutake Y. K., Rindler P. M., Bidichandani S. I., Epigenetic silencing in Friedreich ataxia is associated with depletion of CTCF (CCCTC-binding factor) and antisense transcription. PLoS ONE 2009 4 11, article e7914 2-s2.0-70949099119 10.1371/journal.pone.0007914
33. Babcock M., de Silva D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L., Pandolfo M., Kaplan J., Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 1997 276 5319 1709 1712 2-s2.0-0030846021 10.1126/science.276.5319.1709 (Pubitemid 27421980)
34. Adinolfi S., Iannuzzi C., Prischi F., Pastore C., Iametti S., Martin S. R., Bonomi F., Pastore A., Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nature Structural & Molecular Biology 2009 16 4 390 396 2-s2.0-64049116040 10.1038/nsmb.1579
35. Bulteau A.-L., O'Neill H. A., Kennedy M. C., Ikeda-Saito M., Isaya G., Szweda L. I., Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 2004 305 5681 242 245 2-s2.0-3042763187 10.1126/science.1098991 (Pubitemid 38886737)
36. Lefevre S., Brossas C., Auchere F., Boggetto N., Camadro J. M., Santos R., Apn1 AP-endonuclease is essential for the repair of oxidatively damaged DNA bases in yeast frataxin-deficient cells. Human Molecular Genetics 2012 21 4060 4072 10.1093/hmg/dds230
37. Vaubel R. A., Isaya G., Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia. Molecular and Cellular Neuroscience 2013 55 50 61 10.1016/j.mcn.2012.08.003
38. Ajit Bolar N., Vanlander A. V., Wilbrecht C., van der Aa N., Smet J., de Paepe B., Vandeweyer G., Kooy F., Eyskens F., de Latter E., Delanghe G., Govaert P., Leroy J. G., Loeys B., Lill R., van Laer L., van Coster R., Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe myopathy and encephalopathy. Human Molecular Genetics 2013 22 2590 2602 10.1093/hmg/ddt107
39. Vidal-Quadras M., Gelabert-Baldrich M., Soriano-Castell D., Lladó A., Rentero C., Calvo M., Pol A., Enrich C., Tebar F., Rac1 and calmodulin interactions modulate dynamics of ARF6-dependent endocytosis. Traffic 2011 12 12 1879 1896 2-s2.0-81055156781 10.1111/j.1600-0854.2011.01274.x
40. Peng H.-J., Henkels K. M., Mahankali M., Marchal C., Bubulya P., Dinauer M. C., Gomez-Cambronero J., The dual effect of Rac2 on phospholipase D2 regulation that explains both the onset and termination of chemotaxis. Molecular and Cellular Biology 2011 31 11 2227 2240 2-s2.0-79958047890 10.1128/MCB.01348-10
41. Ooi A., Furge K. A., Fumarate hydratase inactivation in renal tumors: HIF1alpha, NRF2, and "cryptic targets" of transcription factors. Chinese Journal of Cancer 2012 31 413 420 10.5732/cjc.012.10102
42. Adam J., Hatipoglu E., O'Flaherty L., Ternette N., Sahgal N., Lockstone H., Baban D., Nye E., Stamp G. W., Wolhuter K., Stevens M., Fischer R., Carmeliet P., Maxwell P. H., Pugh C. W., Frizzell N., Soga T., Kessler B. M., El-Bahrawy M., Ratcliffe P. J., Pollard P. J., Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 2011 20 4 524 537 2-s2.0-80054767730 10.1016/j.ccr.2011.09.006
43. Papaiahgari S., Yerrapureddy A., Hassoun P. M., Garcia J. C. N., Birukov K. G., Reddy S. P., EGFR-activated signaling and actin remodeling regulate cyclic stretch-induced NRF2-ARE activation. American Journal of Respiratory Cell and Molecular Biology 2007 36 3 304 312 2-s2.0-33847611576 10.1165/rcmb.2006- 0131OC (Pubitemid 46365281)
44. Jiralerspong S., Ge B., Hudson T. J., Pandolfo M., Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Letters 2001 509 1 101 105 2-s2.0-0035976855 10.1016/S0014-5793(01)03140-4 (Pubitemid 33153089)
45. Wilson R. B., Therapeutic developments in Friedreich ataxia. Journal of Child Neurology 2012 27 1212 1216 10.1177/0883073812449691
46. Rustin P., Munnich A., Rötig A., Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron-induced injury in vitro. BioFactors 1999 9 2-4 247 251 2-s2.0-0033000707 (Pubitemid 29289003)
47. Richardson T. E., Yu A. E., Wen Y., Yang S.-H., Simpkins J. W., Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. PLoS ONE 2012 7 4 2-s2.0-84859241592 10.1371/journal.pone.0034600 e34600
48. Enns G. M., Kinsman S. L., Perlman S. L., Spicer K. M., Abdenur J. E., Cohen B. H., Amagata A., Barnes A., Kheifets V., Shrader W. D., Thoolen M., Blankenberg F., Miller G., Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Molecular Genetics and Metabolism 2012 105 1 91 102 2-s2.0-84855355930 10.1016/j.ymgme.2011.10.009
49. Rustin P., von Kleist-Retzow J.-C., Chantrel-Groussard K., Sidi D., Munnich A., Rötig A., Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. The Lancet 1999 354 9177 477 479 2-s2.0-0033533071 10.1016/S0140-6736(99)01341-0 (Pubitemid 29368927)
50. Rustin P., The use of antioxidants in Friedreich's ataxia treatment. Expert Opinion on Investigational Drugs 2003 12 4 569 575 2-s2.0-0037398112 10.1517/eoid.12.4.569.23756 (Pubitemid 36512002)
51. Rustin P., Bonnet D., Rotig A., Munnich A., Sidi D., Idebenone restores mitochondrial respatory chain enzyme activities in the cardiac muscle in Friedreich's ataxia. Neurology 2004 62 524 525 10.1212/WNL.62.3.524
52. Jauslin M. L., Wirth T., Meier T., Schoumacher F., A cellular model for Friedreich ataxia revelas small-molecule glutathione peroxidase mimetics as novel treatment strategy. Human Molecular Genetics 2002 11 24 3055 3063 2-s2.0-1842836406 (Pubitemid 35414819)
53. Richardson T. E., Yang S.-H., Wen Y., Simpkins J. W., Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology 2011 152 7 2742 2749 2-s2.0-79959404165 10.1210/en.2011-0184
54. Marmolino D., Acquaviva F., Pinelli M., Monticelli A., Castaldo I., Filla A., Cocozza S., PPAR- γ agonist azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy. Cerebellum 2009 8 2 98 103 2-s2.0-67949124861 10.1007/s12311-008-0087-z
55. Wallace D. C., A mitochondrial bioenergetic etiology of disease. The Journal of Clinical Investigation 2013 123 1405 1412 10.1172/JCI61398